It has also been observed that SCD1 inhibitors abrogate the protective effects of SCD1 on palmitate-induced lipoapoptotic cell death of β-pancreatic cells [85] Furthermore, different studies in breast cancer models have demonstrated an upregulation of SCD5 in human cancer cells [8]. This evidence concerns the gene SCD and breast cancer.